Clinical Trial Update: LNG-IUS for Treatment of Dysmenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the levonorgestrel-releasing intrauterine system (LNG-IUS) for dysmenorrhea in women with adenomyosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis

Drugs mentioned

• LNG-IUS (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Omar Mamdouh Shaaban | Conditions: Adenomyosis | Phase 2 | Status: COMPLETED